HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/4/E650    most recent 00489.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Daniel, J. A. Articles by Sartin, J. L. Search for Related Content PubMed PubMed Citation Articles by Daniel, J. A. Articles by Sartin, J. L.

Interleukin-1 and tumor necrosis factor- mediation of endotoxin action on growth hormone

¹Animal and Range Sciences, South Dakota State University, Brookings, South Dakota; ²United States Department of Agriculture-Agricultural Research Service Growth Biology Laboratory, Beltsville; ³Cell and Cancer Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and ⁴Department of Anatomy, Physiology, and Pharmacology, Auburn University, Auburn, Alabama

Submitted 18 October 2004 ; accepted in final form 6 May 2005

In humans and sheep, endotoxin (LPS) administration results in increased growth hormone (GH) concentrations. To determine the role of cytokines in the effect of LPS on GH, sheep were challenged with IL-1 or TNF-. GH data were compared with results with LH, where the major effects of LPS are known to act via the hypothalamus. Intracerebroventricular (icv) administration of IL-1 or TNF- did not alter plasma concentrations of GH. Endotoxin was then administered intravenously (iv) in combination with icv injection of IL-1 receptor antagonist (IL-1RA), TNF antagonist (sTNF-R1), or saline. Administration of LPS increased GH (P < 0.0001), although coadministration of IL-1ra or sTNF-R1 icv did not alter GH response to LPS. In contrast, plasma concentrations of LH were profoundly inhibited by icv administration of either cytokine (P < 0.03), but the LH response to LPS was not altered by cytokine antagonists. Intravenous administration of either IL-1 or TNF- increased plasma concentrations of GH (P < 0.0001). Administration of IL-1RA and sTNF-R1 iv prevented LPS-induced increases in GH. Although LH was suppressed by high iv doses of IL-1 (P = 0.0063), the antagonists did not alter the LH response to LPS. To determine whether LPS might directly activate GH release, confocal microscopy revealed colocalization of CD14, the LPS receptor, with GH and, to a lesser extent, LH and some prolactin (PRL)-containing cells, but not ACTH or TSH. These data are consistent with the effects of LPS on GH secretion originating through peripheral cytokine presentation to the pituitary, as well as a potential to act directly on selective populations of pituitary cells via CD14.

luteinizing hormone; cytokines; sheep; CD14; lipopolysaccharide

This article has been cited by other articles:

				J. A. Carroll Bidirectional communication: Growth and immunity in domestic livestock J Anim Sci, April 1, 2008; 86(14_suppl): E126 - E137. [Abstract] [Full Text] [PDF]

				S. Christen, I. Cattin, I. Knight, P. G. Winyard, J. W. Blum, and T. H. Elsasser Plasma S-Nitrosothiol Status in Neonatal Calves: Ontogenetic Associations with Tissue-Specific S-Nitrosylation and Nitric Oxide Synthase Experimental Biology and Medicine, February 1, 2007; 232(2): 309 - 322. [Abstract] [Full Text] [PDF]